Provided by Tiger Trade Technology Pte. Ltd.

Ardelyx

3.78
-0.0050-0.13%
Volume:576.17K
Turnover:2.18M
Market Cap:940.68M
PE:-16.60
High:3.80
Open:3.78
Low:3.76
Close:3.78
52wk High:8.40
52wk Low:3.68
Shares:249.19M
Float Shares:219.00M
Volume Ratio:0.36
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2275
EPS(LYR):-0.2556
ROE:-38.61%
ROA:-4.25%
PB:6.31
PE(LYR):-14.77

Loading ...

Ardelyx to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Yesterday

Have Insiders Sold Ardelyx Shares Recently?

Simply Wall St.
·
Aug 27

Ardelyx Advances Pediatric IBS-C Program With Completed Tenapanor Dose-Ranging Study

TIPRANKS
·
Aug 20

Ardelyx Price Target Maintained with a $9.00/Share by Wedbush

Dow Jones
·
Aug 19

Ardelyx Inc. Balances Record Revenue With Access Risks

TIPRANKS
·
Aug 18

Ardelyx Chief Commercial Officer Eric Foster Resigns Effective Aug. 28

Reuters
·
Aug 18

Ardelyx Leads The Charge With These 3 Compelling Penny Stocks

Simply Wall St.
·
Aug 18

Ardelyx Price Target Cut to $15.00/Share from $16.00 by Piper Sandler

Dow Jones
·
Aug 18

Ardelyx price target lowered to $15 from $16 at Piper Sandler

TIPRANKS
·
Aug 17

Ardelyx Price Target Cut to $11.00/Share from $14.00 by Citigroup

Dow Jones
·
Aug 10

Analysts Are Bullish on These Healthcare Stocks: Immix Biopharma (IMMX), Ardelyx (ARDX)

TIPRANKS
·
Aug 10

Ardelyx Stock Leads These Financially Fit Penny Stocks Worth A Closer Look

Simply Wall St.
·
Aug 09

Ardelyx is Maintained at Buy by TD Cowen

Dow Jones
·
Aug 08

Wedbush Adjusts Price Target on Ardelyx to $9 From $19, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Ardelyx Shares Fall After IBS Drug Sales Hit Snags

Dow Jones
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Ardelyx, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Ardelyx Updates Outlook Amid Q2 Growth and Recalibration

TIPRANKS
·
Aug 07

Ardelyx reports Q2 EPS (7c), consensus (5c)

TIPRANKS
·
Aug 07

Ardelyx Q2 Net Loss Narrows 12.38% to $16.72 Million; Revenue Climbs 31% Year-over-Year to $118.13 Million

Reuters
·
Aug 07